top of page

NEWS ROOM

April 29, 2025

After a Decade of Research, Jowin Launches Revolutionary ORT Therapy to the World

Interview with the Chairman of Jowin – Q&A

July 2, 2024

JOWIN Co., Ltd. Signs Joint Research Agreement With ImpriMed Co., Ltd to Develop Optimal Anti-cancer Adjuvants

AI Precision Medicine Meets Traditional Cancer Treatment: JOWIN and ImpriMed Sign Joint Research Agreement

February 21, 2023

Jowin, the Apple in Korea’s cancer treatment, expands their business globally

Jowin, which has shown great results in clinical trials of many stage 4 and terminal cancer patients in Korea over the past few years, sets this year as its first year of entering the global cancer care market and will establish a global telemedicine platform that provides high-quality non-face-to-face care services to patients with stage 4 and terminal cancer

February 9, 2023

Jowin announces their first year of entering the global cancer care market through their global telemedicine platform

Jowin plans to establish a telemedicine platform for overseas patients with stage 4 and terminal cancer and launch it in the first half of this year

Contact

JOWIN 

89 Mapo-daero, Mapo-gu, Seoul 

Post Tower 4th floor

TEL: 1855-0023

Subscribe to Get My Newsletter

Thanks for submitting!

© 2023 by JOWIN. Proudly created with jowin.co.kr

bottom of page